Galapagos Nv Asset Turnover Ratio (GLPG), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Galapagos Nv  (NASDAQ: GLPG)
 

Galapagos Nv Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Galapagos Nv asset turnover ratio, the ability of Galapagos Nv's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.33 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as GLPG's position remain challenging.

Within sector 3 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 51.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GLPG Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -18.33 % -17.63 % -17.63 % -17.63 % -2.7 %
Y / Y Revenue Change 303.5 % - - - 14.99 %
Asset Turnover Ratio (TTM) 0.33 - - - 0.07
GLPG's Total Ranking # 51 # 0 # # #
Seq. Asset Change -1.53 % 0 % 0 % -17.07 % -0.68 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 7
Overall Market # 51

Asset Turnover Ratio Statistics
High Average Low
375.89 81.74 8.09
(Dec 31 2025)   (Dec 31 2023)




GLPG Company Profile • Back to GLPG Efficiency Comparisons • Compare GLPG Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Indivior Pharmaceuticals Inc   0.91 $ 1,240.000  Millions$ 1,361.000  Millions
Novavax inc   0.90 $ 1,123.479  Millions$ 1,246.486  Millions
Adma Biologics Inc   0.90 $ 508.113  Millions$ 565.470  Millions
Pediatrix Medical Group Inc   0.90 $ 1,913.849  Millions$ 2,135.420  Millions
Genedx Holdings Corp   0.89 $ 427.173  Millions$ 481.976  Millions
Lakeland Industries Inc   0.88 $ 192.648  Millions$ 218.770  Millions
Ardelyx inc   0.87 $ 407.320  Millions$ 466.184  Millions
Travere Therapeutics Inc   0.87 $ 490.728  Millions$ 561.970  Millions
Enhabit Inc   0.87 $ 1,060.000  Millions$ 1,214.175  Millions
Lifeward ltd   0.87 $ 22.034  Millions$ 25.414  Millions
Encompass Health Corporation  0.87 $ 5,935.200  Millions$ 6,845.600  Millions
Si bone inc   0.86 $ 200.879  Millions$ 232.757  Millions
Tarsus Pharmaceuticals Inc   0.86 $ 451.360  Millions$ 523.116  Millions
Amneal Pharmaceuticals Inc   0.86 $ 3,018.308  Millions$ 3,516.548  Millions
Apyx Medical Corp  0.86 $ 52.044  Millions$ 60.638  Millions
Atricure Inc   0.85 $ 531.942  Millions$ 622.525  Millions
Caredx Inc   0.85 $ 379.805  Millions$ 444.858  Millions
Yunhong Green Cti Ltd   0.85 $ 19.590  Millions$ 22.991  Millions
Carlisle Companies Incorporated  0.85 $ 5,019.900  Millions$ 5,922.475  Millions
Fennec Pharmaceuticals Inc   0.85 $ 44.642  Millions$ 52.773  Millions
Verrica Pharmaceuticals Inc   0.84 $ 35.577  Millions$ 42.328  Millions
Teladoc Health Inc   0.84 $ 2,529.977  Millions$ 3,018.824  Millions
Eton Pharmaceuticals Inc   0.83 $ 79.740  Millions$ 95.583  Millions
Xeris Biopharma Holdings Inc   0.83 $ 291.845  Millions$ 350.964  Millions
Bionexus Gene Lab Corp   0.83 $ 7.425  Millions$ 8.944  Millions
Exelixis Inc   0.83 $ 2,320.126  Millions$ 2,795.824  Millions
Madrigal Pharmaceuticals Inc   0.83 $ 958.403  Millions$ 1,158.514  Millions
Incyte Corporation  0.83 $ 5,141.242  Millions$ 6,214.762  Millions
Penumbra Inc  0.82 $ 1,403.665  Millions$ 1,709.751  Millions
Insulet Corporation  0.82 $ 2,708.100  Millions$ 3,301.550  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.